*Some Market data delayed by 15 mins.

Dyne Therapeutics, Inc. Common Stock

Symbol: DYN (NASDAQ)
41.53 ▼ (-1.04%) -0.435

Company Description:
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Key Stats
  • Today's Open: $42.56
  • Today's High: $42.34
  • Today's Low: $39.981
  • Today's Volume: 790.56K
  • Yesterday Close: $41.96
  • Yesterday High: $42.31
  • Yesterday Low: $39.93
  • Yesterday Volume: 1.26M
  • Last Min Volume: 3
  • Last Min High: $41.525
  • Last Min Low: $41.525
  • Last Min VWAP: $41.525
Company Profile
  • Name: Dyne Therapeutics, Inc. Common Stock
  • Website: https://www.dyne-tx.com
  • Listed Date: 2020-09-17
  • Location: WALTHAM, MA
  • Market Status: Active
  • CIK Number: 0001818794
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $4.13B
  • Round Lot: 100
  • Outstanding Shares: 99.46M
  • Asset Type: CS
RECENT FILINGS FOR DYN
Filing DateFiling TypeFormat
2024-07-034/AView
2024-06-244View
2024-06-21144View
2024-06-134View
2024-06-114View
2024-06-114View
2024-06-114View
2024-06-114View
2024-06-114View
2024-06-11144View
2024-06-11144View
2024-06-11144View
2024-06-11144View
2024-06-10144View
2024-06-10144View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.